Integrating Molecular Testing into Decision Making in NSCLC

home / insights / integrating-molecular-testing-into-decision-making-in-nsclc

A panel of oncologists share insights on molecular testing in non-small cell lung cancer (NSCLC) and how they integrate and interpret the results to optimize treatment selection for their patients.

Sponsored in part by Takeda Oncology. Content independently developed by OncLive.

Challenges With and Strategies for Tissue Procurement in NSCLC

EP. 1: Challenges With and Strategies for Tissue Procurement in NSCLC

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
October 12th 2022

Drs Benjamin Levy, Neil Morganstein, and Bhuvana Ramkumar discuss challenges of procuring for molecular testing in patients with NSCLC.

Enhancing Communication Among the Multidisciplinary Care Team

EP. 2: Enhancing Communication Among the Multidisciplinary Care Team

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
October 12th 2022

Bhuvana Ramkumar, MD, and Neil Morganstein, MD, share standards of communication among the care team at their clinical practice sites.

Best Practices for Accurate Tissue Genotyping in NSCLC

EP. 3: Best Practices for Accurate Tissue Genotyping in NSCLC

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
October 19th 2022

Dr Bhuvana Ramkumar shares best practices for molecular testing in NSCLC to obtain the most accurate results.

Average Turnaround Time for NSCLC Molecular Testing

EP. 4: Average Turnaround Time for NSCLC Molecular Testing

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
October 19th 2022

Dr Neil Morganstein explains the typical turnaround times for molecular testing he sees and the challenges that prolong the process.

Types of Tissue Next-Generation Sequencing Platforms in NSCLC

EP. 5: Types of Tissue Next-Generation Sequencing Platforms in NSCLC

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
October 26th 2022

Experts discuss the types of genotype panels they often use for testing patients with NSCLC, and why.

Using Liquid Biopsy for Molecular Testing in NSCLC

EP. 6: Using Liquid Biopsy for Molecular Testing in NSCLC

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
October 26th 2022

Bhuvana Ramkumar, MD, highlights the strengths of liquid biopsy for molecular testing in NSCLC.

Integrating Molecular Testing Results into Electronic Medical Records

EP. 7: Integrating Molecular Testing Results into Electronic Medical Records

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
November 2nd 2022

The panel reflects on challenges with the EMR, and the impact it has on treatment decision making for their patients with NSCLC.

Receiving Molecular Testing Results for NSCLC

EP. 8: Receiving Molecular Testing Results for NSCLC

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
November 2nd 2022

Bhuvana Ramkumar, MD, and Neil Morganstein, MD, share if they believe there should be a standard for molecular testing reports, and how frequently they communicate with their patients during the process.

Financial Considerations with Molecular Testing for Patients With NSCLC

EP. 9: Financial Considerations with Molecular Testing for Patients With NSCLC

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
November 9th 2022

Drs Morganstein and Ramkumar detail the financial considerations patients and physicians face during the process of molecular testing for NSCLC.

The Future of Molecular Testing in NSCLC

EP. 10: The Future of Molecular Testing in NSCLC

Benjamin Levy, MD;Bhuvana Ramkumar, MD;Neil Morganstein, MD
November 9th 2022

The panel closes by highlighting unmet needs in molecular testing, and advances they are looking forward to.